Zhengcheng Liu

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

Zhengcheng Liu is an author at Nanjing Drum Tower Hospital specializing in exosome-based therapy, microrna function in cancer, and tumor-derived exosomes.

ORCID

Publications per year

2022–2024

Publications

Immune Checkpoint Inhibitor Combined with Antiangiogenic Agent Synergistically Improving the Treatment Efficacy for Solid Tumors

Yong Zhou, Zhengcheng Liu, Ao Yu et al. · ImmunoTargets and Therapy · 2024 · 21 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

MiR‐1246 is responsible for lung cancer cells‐derived exosomes‐mediated promoting effects on lung cancer stemness via targeting TRIM17

Zhengcheng Liu, Wei Zhao, Rusong Yang · Environmental Toxicology · 2022 · 18 citations

Medicine, Molecular Biology, Oncology +16

1–2 of 2